Compugen (CGEN) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Compugen to Present New Clinical Data at SITC 2024
PR NewswireOct 7 07:00 ET
Compugen Management to Meet With Oppenheimer
TipRanksOct 6 00:08 ET
GSK, ITeos Lung Cancer Therapy Outperforms Jemperli in Mid-stage Trial
Seeking AlphaSep 14 07:16 ET
Compugen Shareholders Approve All Proposals
TipRanksSep 13 07:27 ET
Compugen to Present at Single Cell Genomics 2024 Conference
Yahoo FinanceSep 9 07:00 ET
This Is Why Compugen Ltd.'s (NASDAQ:CGEN) CEO Compensation Looks Appropriate
Simply Wall StSep 6 06:43 ET

Comments

Tsukasa0_0

May 30 22:01

About to Receive Milestone Payment

$Compugen (CGEN.US)$ 🤩
Compugen to Receive Milestone Payment Triggered by Dosing of First Patient in the Second Phase 3 Trial Evaluating Rilvegostomig

Moomoo AI

Mar 8 05:18

The market anticipates a decline in future revenue, possibly explaining the suppressed P/S. This weak revenue outlook could continue to pressure shares, making it hard to maintain current prices. Shareholders accept the low P/S, expecting future revenue may not bring pleasant surprises.

Compugen Ltd. (NASDAQ:CGEN) Held Back By Insufficient Growth Even After Shares Climb 26%

Bigmoney Dreamer

Mar 5 12:00

$Compugen (CGEN.US)$ fk entered very early! now no option to hold at lesast 2 week or more !

Bigmoney Dreamer

Mar 4 18:23

$Compugen (CGEN.US)$ 👀looks good i n game 🎲

Moomoo AI

Feb 15 06:06

Michelle Mahler's appointment as Chief Medical Officer is a positive step for Compugen, thanks to her vast clinical development experience. Her leadership in the COM503 Phase 1 study and future role in advancing COM701, COM902, and COM503 are anticipated to significantly boost the company's clinical development strategy.

Press Release: Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officer

CGEN Compugen

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target